Cost-Effectiveness of Medically Monitored Ibogaine for Opioid Use Disorder in Tennessee: A State-Specific Semi-Markov Analysis
June 30, 2026 T Wagner, Gaetano Lardieri, KD Adams
Background: Opioid use disorder remains a major public health and healthcare-system challenge in Tennessee, where many adults remain untreated, undertreated, or poorly retained in care. Medically monitored ibogaine has been proposed as a potential intervention for OUD, but its economic implications in a state treatment environment have not been well characterized. We evaluated the health and...